The legal back-and-forth over…
The legal back-and-forth over migraine meds from Teva and Eli [...]
Astellas will close a stem cell…
Astellas will close a stem cell therapy site. GSK is [...]
Viatris and Teva Pharmaceutical…
Viatris and Teva Pharmaceutical Industries recently launched separate recalls related [...]
The FDA’s Pharmacy Compounding…
The FDA’s Pharmacy Compounding Advisory Committee will convene this summer [...]
Travere is eyeing a collective $3…
Travere is eyeing a collective $3 billion U.S. opportunity for [...]
Even as Eli Lilly gets underway…
Even as Eli Lilly gets underway with its next major [...]
Protagonist Therapeutics-partnered…
Protagonist Therapeutics-partnered Icotyde has the potential to become one of [...]
Eli Lilly has chalked up another…
Eli Lilly has chalked up another victory in the chronic [...]
GSK and Shionogi’s ViiV…
GSK and Shionogi’s ViiV Healthcare is seeking to raise awareness [...]
As geopolitics bring reshoring…
As geopolitics bring reshoring interest to a fever pitch, the [...]